FENOFIBRATE 160/200mg CAPSULE

Product description

UNIQUE SELLING POINT 
  • Fenofibrate reduces LDL  concentration in plasma. Also reduces coronory artery  disease risk.
  • Fenofibrate activates peroxisome proliferator activated receptor type alpha (PPARa) that increases the lipolysis and elimination of  atherogenic particles. 

Read more

Specifications

Details Strenght:50.25mg/0.5mg/1mg/2mg
Categories Pharmaceutical PackagingBlister Packaging
Sales markets Western Europe; Eastern Europe; Middle East; Asia
Supplied from India
Measured In mg
Selling Points International Approvals/Standards
Show more specifications

More products from Athena

View all our products (14)

Products from other suppliers

FENOFIBRATE 160/200mg CAPSULE

Contact information

Address

Telephone

Website

View all contact information